Presented by Andy Moores and Alex Belch, 'Plates and Screws - An Introduction' is aimed at surgeons with no prior experience of applying plates and screws, and offers seven hours of CPD.
Andy said: "If you've ever wondered if orthopaedics is for you, or you just need an introductory course to get you started, this could be the perfect opportunity.
"The course should be particularly useful for junior colleagues: the tutors are very friendly and it's great value thanks to sponsorship from Veterinary Instrumentation and the BVOA.
Tickets cost £200 (plus £40 for non-members): https://bvoa.co.uk/wp-content/uploads/2023/07/Plating-registration-form.pdf
The BVOA 60th Anniversary Conference follows from 12th-14th October at the same venue.
Titled "Back to the Future, the conference features talks by Mike Farrell, Antonio Pozzi, Stuart Carmichael and others, covering subjects such as fracture repair, joint pathology, imaging techniques and osteoarthritis.
There'll also be a chance to look round HMS Belfast, and a gala black tie dinner.
Tickets start at £250 for a single day, up to £795 for the full conference package.
Brand Manager Dr Amy Scott said: "Because pain is often very difficult for owners to spot, the website highlights some of the common signs that indicate their cat or dog is suffering.
"We have also included a range of additional measures that owners can take to improve the quality of life and maintain the joint health of their pet once Metacam has been prescribed. These include weight management, regular and gentle exercise and alternative therapies such as hydrotherapy or the use of joint supplements such as Seraquin."
The website highlights common painful conditions such as arthritis, as well as more acute scenarios such as post injury or surgery. It also describes the changes in behaviour owners should be aware of that could indicate their pet is in pain, for example reluctance to exercise, change in appetite, displays of aggression or depression.
Amy added: "The correct use of NSAIDs is also an important consideration for effective pain management. To help with this, the website contains a section on Metacam administration for owners, featuring a short video on accurate dosing and treatment."
Carried out by the Royal Veterinary College (RVC), the Animal Health Trust (AHT) and Rossdales Equine Hospital, the study also revealed that the groups particularly at risk were native pony breeds and their crosses, as well as horses and ponies with a history of laminitis and those with lameness or soreness after routine hoof care.
This research, funded by World Horse Welfare, comes from the first ever online study that collected information on laminitis from a group of owners in real time.
The researchers say that the study is also the second largest to identify weight gain as a risk factor for laminitis. Data was collected from the owners of 1,070 horses and ponies in Great Britain, who reported their animal’s management, health and estimated weight via online questionnaires for 29 months.
Owners were encouraged to use a custom weight tracking tool designed by the study/research team to help regularly track changes in their animal’s weight and body condition. The uptake of this tool was high, with over half of participating owners using it.
The tool is freely available at: www.aht.org.uk/research/lameness/laminitis.
Other study findings included:
A high risk of laminitis was present in horses shod or trimmed at intervals of more than 8 weeks, and in those that took a long time to return to soundness after a bout of laminitis.
Diet, grazing management and health were factors closely associated with the development of laminitis and will be the subject of future investigation.
Researchers also noted that weight gain often occurred unintentionally, even when owners were aiming for their animals to maintain or lose it. This reiterates the need to consistently record weight and body condition in order to prevent undesirable weight gain.
Dr. Dee Pollard of the AHT, one of the study’s chief authors, said: "This is one of the largest, and the first, online laminitis studies where we collected regular information from the same group of owners in real-time. We assessed the relationship between laminitis and many potential management and health factors and identified those more likely to be present before a laminitis episode was reported.
"We now have good evidence to develop laminitis prevention guidelines, and a number of different avenues to explore in the future. We cannot emphasise enough how important systematic and regular weight and body condition monitoring are. It’s very easy to miss weight gain when you are just relying on your eyes and you see your horse or pony every day. You need to get hands on, feel for the fat deposits and take measurements, remember the figures don’t lie!"
Reference
Dr Henry faced one charge, that in January 2020 she wrote and/or signed an undated letter confirming that a ewe had died in transit to the surgery due to dystocia and peri-parturient stress, when in fact she had euthanised the animal at the veterinary practice the day before. The letter, which was addressed 'To whom it may concern’, was on practice letterheaded paper and signed "Louise Henry MRCVS".
The second part of the charge outlined that her conduct concerning the letter was dishonest.
The Committee heard that the ewe was lambing and brought to the practice by a client. Dr Henry was on-call at the time and advised a Caesarean section. The client agreed and Dr Henry delivered two live lambs and one dead lamb.
Dr Henry was concerned about the welfare of the ewe post-surgery because of the risk of peritonitis and advised that the ewe should be euthanised.
The client agreed to the ewe being euthanised and then asked Dr Henry to write a letter in which it was stated that the ewe had died in transit on route to the practice. Dr Henry agreed to write the letter in which she falsely certified that the ewe had died in transit.
The letter came to light when the practice director found it in an insurance file. The practice arranged an investigatory meeting with Dr Henry where she admitted that writing the letter was an error of judgement. When asked about her conduct, Dr Henry explained that the client had subsequently been dissatisfied with the letter she had written and asked her to change it. She refused to amend the letter and told him that it was wrong of her to have written it in the first place and that she regretted having done so.
Dr Henry told the Committee that she valued integrity very highly and that she was deeply ashamed that she had been prepared to write the dishonest letter.
The Committee heard several testimonials from people who had worked with or studied alongside Dr Henry, who all attested to her skill as a veterinary surgeon and that they had no concerns about her integrity and honesty. She self-reported her actions from January to the RCVS and from the outset admitted the facts of the charge. During the hearing, Dr Henry submitted that her action of dishonest false certification amounted to disgraceful conduct in a professional respect.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “The Committee considered that, in this case, the aggravating features were limited and the mitigating factors extensive. There was no premeditated dishonesty or financial gain involved, there was no actual harm or risk of harm to an animal or human and this was a single incident in an otherwise unblemished 13-year career. The Committee found that the shame and remorse expressed by Dr Henry were entirely genuine. Her conduct on this occasion was entirely untypical of her practise.
“After careful consideration, the Committee concluded that the substantial mitigating features permitted it to take the somewhat unusual course of issuing a reprimand in a case involving dishonesty. In taking this course, the Committee attached significant weight not only to the isolated nature of the event but also to the genuine insight shown by Dr Henry and the lasting impact this event has had upon her. In the Committee’s assessment, a reasonable and fully informed member of the public would, in this particular case, regard a reprimand as a sanction which protected the public interest in the profession and upheld its standards.”
The full documentation for the hearing can be found at www.rcvs.org.uk/disciplinary
The campaign is being fronted this year by a number of social media influencers, appropriately including Cat the Vet, aka Cat Henstridge (pictured right), Louisa The Vet and Alex And Bump.
Ceva has produced a number of materials to help practices get involved, including social media posts and templates which are now available from Ceva Territory Managers, or from the veterinary social media platform, Vet Social.
The company will also be launching an educational video that helps people recognise that older cats, and those with concurrent diseases, may have high blood pressure but show little in the way of recognisable signs.
Suzanne Page, Veterinary Surgeon and Amodip Product Manager at Ceva, said: “This year, in recognition of how busy practices are, we wanted to give veterinary teams resources that provide a straightforward and simple way to raise feline hypertension awareness.
"Hypertension is so difficult for owners to notice, so we are working hard with influencers to spread the word.
"There will also be leaflets to share and a new website for cat owners at www.catbloodpressure.com.”
For those wanting to brush up on hypertension, there's Ceva's free CPD course, led by Dr Sarah Caney, Feline Medicine Specialist and CEO of Vet Professionals, available here.
Norbrook has launched Loxicom 0.5mg/ml oral suspension for small dogs, indicated for the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders.
Loxicom Oral Suspension comes in a clear 15ml bottle which allows vets and clients to monitor levels of the product and re-order when necessary.
Loxicom 0.5mg/ml for Dogs comes with two sizes of syringe, a 1ml syringe graduated from 0.25kg-5kg to treat even the smallest of dog breeds accurately, and a 5ml syringe graduated from 1kg-25kg to treat small and medium dog breeds. The syringes plug securely into the bottle to ensure a tight-fitting connection and minimal leakage when administering the product.
This new oral suspension joins the range of 1.5mg/ml oral suspensions for Dogs and 5mg/ml injections for Dogs and Cats, launched in 2009, and the 0.5mg/ml oral suspension for Cats launched earlier this year at the BSAVA Congress.
Mark will be cycling the 100-mile route, the same as was used in the 2012 London Olympics, on Sunday 30th July.
Mark said: "Having worked in veterinary medicine for more than 20 years, I have have come to appreciate that it is a career with highs as well as lows. That some days are going to be pure gold, but others are likely to be emotionally tough and stressful. In those times mental health can be tested and that's where services like Mind really come into their own. I'd like to advertise their work and raise some money at the same time by cycling this event for them.
"I have wanted to support Mind for a long time and the Prudential 100 is a local event that gives me an opportunity to support their great work."
If you'd like to support Mark's efforts, you can do so at: http://uk.virginmoneygiving.com/markturner31
Bayer Animal Health has announced it'll be running the 'Be Lungworm Aware' campaign in April 2011. The campaign is targeted at dog owners to raise awareness of the risks associated with the lungworm Angiostrongylus vasorum.
A Bayer spokesman said: "Over the past years, the spread of A. vasorum has been cited by independent experts, and disease caused by this parasite is increasingly diagnosed. Previous lungworm awareness campaigns have been successful in increasing dog owner awareness of A. vasorum and how their dogs can become infected. However, there is still a lack of recognition as to the signs associated with this infection, so the continuing education of dog owners is extremely important."
The national 'Be Lungworm Aware' activity for April includes TV, radio and print advertising in the form of an educational 'public information' style feature. A national awareness day is also planned for 6 April, which will include radio broadcast and web chat TV, and feature veterinary surgeon Luke Gamble and TV presenter Jenni Falconer.
Bayer has produced a package of veterinary support materials to allow practices to take part in the campaign and raise awareness at a local level. Materials include: an educational waiting room wall display and DVD, and client leaflets. A PR pack has also been produced which contains useful images and information which can be used on websites and in newsletters, as well as a press release for issuing to the local media and radio stations. To order these support materials, practices should contact their local Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.
Members of the profession are of course more likely than most to receive information about violent incidents that constitute abuse against an animal, and research has shown that such cases are often the index case that trigger investigation into violent households.
Jennie Bartholomew, education coordinator at the BSAVA said: "Suspecting animal abuse can be an alarming and sensitive issue to confront but our training courses should give veterinary teams the skills and support they need to help deal with such cases."
The sessions will provide guidance on setting up a practice protocol and identifying a Safeguarding Liaison Officer (SLO) who will aid practice staff in suspected cases of abuse. Through the SLO, relationships with RSPCA officers, police domestic abuse officers and aid agencies can be set up to give staff expert support to call upon if they suspect animal or human abuse.
Freda Scott-Park is a BSAVA Past President and is one of the lecturers on the Links Veterinary Training Initiative courses. She said: "There are few veterinary practices that do not encounter animal abuse, not daily, but the incidence is increasing.
"Cases can be quite complicated to diagnose but often vets find they develop a sixth sense that something isn’t right. By defining the complexities and difficulties in diagnosis, the course aids vets, veterinary nurses and receptionists to understand how to proceed – to ask the right questions and how to seek help from the correct people.
"Information from the veterinary practices may allow human healthcare professionals to investigate troubled households, offering support to the family and potentially improving or saving a human victim’s life."
Three sessions have been organised around the country during 2019. They are free for BSAVA members, with a non-member price of £40.00.
Sunday 23 June: Wetherby Racecourse, Yorkshire
Monday 16 September: Woodrow House, Gloucester
Sunday 27 October: Jesus College, Cambridge
Zoë Coker, a co-founder of VETbytes alongside Bronwen Eastwood, said: "This new feature will allow users to access real-time updates to the app so they can be assured they are following the most up-to-date clinical guidance."
The app, which was launched in partnership with the BSAVA earlier this year, covers more than 100 topics and includes other features such as drug (and CRI) calculators, a quick reference section and links to hundreds of source abstracts, as well as CPD accreditation for reflective learning.
It is available at a discount to BSAVA members and free to veterinary students.
BSAVA President Professor Ian Ramsey said: “The latest addition to the app advances our joint goal with VETbytes, to provide the latest practical, accessible, evidence-based resources for the small animal veterinary community.”
To view the ‘latest updates’ feed: https://vetbytes.co.uk/latest-updates.
For more information, visit: www.vetbytes.co.uk.
Genitrix has launched Dentagen, billed as the UK’s first dental plaque protection system for dogs and cats.
The active principle in Dentagen is a plant extract called RF2 and the product operates as an ‘anti-biofilm’ treatment by modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations.
Dentagen wax is presented for practice use in a syringe for easy application to the gingival layer and the buccal area of teeth. The initial protective coating of wax is applied to dogs or cats at end of dental procedures in practice and while the animal is still sedated. The coating lasts for two to three days.
Dog owners can then maintain the protective coating by giving their pet Dentagen plaque prevention chews every other day. The chews, impregnated with RF2 and of a specially designed shape and consistency, are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg.
Vet Katy Horton of White Hart Lane Vets, who has trialled the product, commented: “The Dentagen wax was certainly very easy to apply and, from the small sample of dogs we’ve so far tried it on, the palatability of the chews was good. While tooth-brushing remains the gold standard for dental care, we recognise that it can be difficult for owners and believe that this new approach could be a valuable alternative.”
Five syringes of Dentagen for application in practice cost £12.50. Packs of nine small chews cost £5.10 while a pack of the larger chews costs £6.50.
The RCVS Disciplinary Committee has dismissed a case against an Essex-based veterinary surgeon, having found him not guilty of charges relating to the measurement of horses and ponies.
At the ten-day hearing, Marc Auerbach of Oak Equine Veterinary Surgery, Ongar, answered charges relating to measuring the height of 29 horses/ponies presented for measurement by two agents in early 2009. Dr Auerbach had undertaken these measurements as an Official Measurer (OM) for the Joint Measuring Board (JMB), which provides a system for independently measuring and certifying the size of competition horses/ponies. An animal's financial value relates to its size, with larger animals being more likely to win in their competitive class.
The case centred on the expected accuracy of such measurements, whether Dr Auerbach was dishonest in colluding with the agents, or whether there had been signs of malpractice which a reasonably competent vet acting as an OM ought to detect.
From evidence submitted, the Committee determined a margin for measurement accuracy, and consequently dismissed from its consideration ten animals where the difference between the initial measurement and the re-measurement was 3 cm or less. However, the College submitted that the average difference was so great that, either, Dr Auerbach had failed to take sufficient steps to ensure that the correct measurements were recorded, or else he had been dishonest. Dr Auerbach's Counsel accepted the inference that presenting agents were dishonest, but denied that Dr Auerbach was dishonest or had failed to pick up signs of malpractice on the part of the agents.
The Committee was of the view that there may be unscrupulous presenters capable of materially interfering with the height of horses. While it was unable to determine with certainty the extent to which it could be done, the Committee formed the view that unscrupulous interference (together with intrinsic variables) could have caused the differences between measurement and re-measurement in the 19 horses.
The Committee noted there was no evidence of improper payments being received by anyone. It also accepted evidence that Dr Auerbach was not a dishonest man, taking into account his record of 23 years of honesty and excellence in the profession, unchallenged character references and the lack of any credible motive for him to act dishonestly.
Next, the Committee considered whether there had been signs of preparation malpractice which ought to have been picked up by any reasonably competent veterinary surgeon acting as an OM. The College submitted that Dr Auerbach had failed to take several steps including the amount of time and attention given to the animals he measured, and whether they might be drugged or sedated.
The Committee concluded from the evidence, including scientific papers, that mildly sedated animals may not be distinguishable from properly prepared animals; well-behaved horses were not an indication that something was amiss. The Committee accepted that Dr Auerbach took around 15-20 minutes to measure each of the horses presented on 9 January; and, in the absence of guidance from the JMB, it could not conclude this was rushed or unreasonable. Consequently, the Committee was unable to be satisfied, so that it was sure, that the allegation of failure to take sufficient steps to ensure the recording of correct measurements was proved.
"Accordingly, the decision of the Committee is that the facts set out in the Charge in relation to all the horses and ponies listed have not been proved to the necessary standard of proof," said Prof Peter Lees, speaking on behalf of the Committee as he directed the charges be dismissed.
Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.
The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.
Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''
To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.
Following the launch of Libromide, the only licensed formulation of potassium bromide in the UK for canine epilepsy, Genitrix has linked up with NationWide Veterinary Laboratories to offer a discounted blood test service to veterinary practices.
Genitrix says it is offering the discounted blood tests to help practices and encourage owners to test regularly, thus ensuring that the level of Libromide in dogs undergoing treatment remains within the recommended therapeutic range.
According to the company, factors which can cause the level to move out of therapeutic range include an increase in the chloride content of the diet or the administration of other drugs. Because Libromide takes a few weeks to reach a steady therapeutic state, testing at four, eight and twelve weeks is also recommended at the commencement of treatment to confirm that the rise to therapeutic level takes place.
To take advantage of the discount scheme, practices can download a test form from the Genitrix website (http://www.genitrix.co.uk/) or call its head office on 01403 786345. Copies are also available from wholesalers.
Rob Watkins, Marketing Director at Genitrix, said: "Regular blood testing of epileptic dogs is an essential element of a successful treatment regime and is recommended by all canine epilepsy specialists. Unfortunately, feedback from practices suggests that owners are sometimes reluctant to comply with this advice and that the cost of testing is frequently an issue.
"We've launched the scheme to help practices increase compliance by making it significantly cheaper. Taking advantage of this scheme for blood testing is also convenient for practices now that the test forms can be downloaded as well as ordered by phone.
"Recent data suggests that canine epilepsy affects four in every hundred dogs making it a common disease affecting dogs in the UK. Following on from the launch of Libromide, we hope that the discounted blood test scheme will be another step forward in the move to improve treatment approaches for this distressing disease."
Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.
The Cat Cabin Fever campaign will run for four weeks.
Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour. Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat. "However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment." Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR. For more information, visit: http://www.feliway.co.uk/.
Ceva Animal Health has announced the addition of a new CPD module to its Cardio Academy, covering the clinical significance of heart murmurs in cats.
Hosted by Virginia Luis-Fuentes, Professor of Veterinary Cardiology at the Royal Veterinary College, the online seminar provides guidance in deciding which heart murmurs are significant and working out which are more likely to develop complications, such as congestive heart failure or aortic thromboembolism.
According to the company, up to 40% of cats will have heart murmur at some point in their life, but are often clinically normal at presentation. To make things more confusing, says Ceva, 50% of cats with congestive heart failure do not have a heart murmur at all.
The module lasts for 20 minutes and, after viewing, delegates receive a CPD certificate by answering questions relating to the session.
To access this module, and 20 hours of online cardiology CPD, visit www.cardioacademy.cevalearn.com.
Veterinary nurses, veterinary surgeons, students and other veterinary professionals are all invited to take part in the anonymous survey and share incidents where they have witnessed discrimination or felt discriminated against.
The survey covers the nine protected characteristics under the Equality Act: age, gender reassignment, marital or partnership status, being pregnant, disability, race, religion, sex and sexual orientation. It also includes other forms of discrimination which might not fit under these characteristics, such as body weight and socio-economic background.
BVA Junior Vice President Daniella Dos Santos said: "The veterinary professions should be open, welcoming and supportive of everyone; however, it is clear from the reports we’re hearing that discrimination is still an issue. Worse still, we’re aware that some colleagues have faced a backlash when talking about their experiences of discrimination. This is completely unacceptable.
"If we hope to prompt meaningful change we need to fully understand the scale of the problems our colleagues are facing. To do that it’s important that we provide a safe, anonymous space for everyone to share their experiences. We hope this questionnaire will give people that opportunity and we would like to sincerely thank our colleagues for their willingness to share their personal experiences with us."
The survey was developed with the support of the British Veterinary Ethnicity and Diversity Society (BVEDS) and British Veterinary LGBT+.
BVA says it intends to gather further quantitative data on discrimination via its Spring Voice of the Veterinary Profession Survey 2019.
The questionnaire is open from 2 February until 2 March and should take around 10 minutes to complete. A link to the questionnaire is available here.
The 2020 OV Conference will offer up to 25 hours of CPD with lectures, workshops and Q&A sessions from world-class speakers in streams covering small animals, farm animals and equines. There will also be exclusive offers from industry sponsors and online networking opportunities.
The OV Conference provides an opportunity for OVs to discuss current topics of interest and recent developments in their work. Themes this year will include notifiable diseases, biosecurity and disease control, and export certification.
In addition to the live lectures, delegates will be able to view recordings of all the sessions on-demand for three months following the conference. The CPD on offer counts towards OV revalidation qualifications with the event open to all vets, as well as animal health paraprofessionals, nurses and practice managers.
David Babington MRCVS, Business Development Director at Improve International, said: "Moving the OV Conference online has given us an opportunity to harness the technology we use regularly in all of our veterinary training to bring OVs an exceptional but affordable CPD experience.
"Our excellent speakers are looking forward to sharing the latest updates in all aspects of OV work with our delegates and to discussing the challenges ahead, particularly in the light of the COVID-19 pandemic and with the UK moving inexorably towards leaving the EU at the end of the year.
"We’re looking forward to meeting our delegates old and new online at the OV Conference in September.”
The full programme and tickets are now available from https://officialvet.com
The first 150 tickets will get an ‘Early Bird’ 25% discount from £160 to £120+ VAT using the code UK.OV.EARLYBIRD.
Protexin Veterinary has launched Cystophan, a new product to aid in the management of Feline Idiopathic Cystitis (FIC).
Protexin says nearly 50% of cats with FIC will have a recurrent signs within one year, so it is important to offer a high quality product to manage the condition correctly.
Cystophan combines 3 key ingredients in a tasty artificial chicken flavour capsule for optimum effectiveness:
Cystophan is available in tubs of 30 and 240 capsules.
For further information please visit www.protexin.com.
Animal Health and Veterinary Laboratories Agency (AHVLA) has announced the formation of a new independent advisory group to recommend a future delivery model for veterinary surveillance in England and Wales.
The Advisory Group will be chaired by Dirk Pfeiffer, Professor of Veterinary Epidemiology at the Royal Veterinary College. According to the AHVLA, it will include representatives from government, the veterinary profession and the livestock farming and private laboratory industries and is being created so all those with an interest in veterinary surveillance can shape a future model and ensure that all issues are thoroughly considered.
Veterinary surveillance seeks to identify new or re-emerging threats to our livestock population and to public health. It involves a partnership approach between livestock keepers, private veterinary surgeons, the Scottish Agricultural College, industry bodies and AHVLA in order to effectively gather and assess intelligence.
AHVLA is seeking to identify ways to undertake veterinary surveillance both more effectively and at an affordable cost to the taxpayer. Work in this area has been on-going since 2010, and the merger of the former Animal Health and Veterinary Laboratories Agency (VLA) has created opportunities to review how veterinary surveillance can best be delivered.
The new model will aim to address capacity imbalances in the current service where provision sometimes outstrips demand. The independent advisory group are also expected to recommend how better and closer working methods across the partners can make the surveillance stronger as well as more cost effective.
Surveillance has historically been based on in-depth investigation of disease incidents with an emphasis on post mortem examinations carried out at AHVLA's regional laboratories. This system is a key element in the government's risk-based approach to the management of animal disease related threats.
AHVLA says that the current model, although successful in identifying diseases in the past, can be improved upon. A recent internal AHVLA report identified viable options for achieving better surveillance at the same or lower cost by, for example, exploring moving towards risk and intelligence based surveillance and improving the value added by working more closely in partnership with vets and their farmer clients and other sources of intelligence data.
In mid-January 2012, AHVLA will also be publishing, and publicising, an online survey aimed at individual veterinary practioners and livestock keepers. The survey will seek individual opinions on the inputs, mechanisms, outputs and value of surveillance in England and Wales Work is expected to run until spring 2012, following which recommendations on a way forward will be made.
Carl Padgett, President of the BVA, said: “Veterinary surveillance is an essential component in our animal health, public health, food security, and international trade work.
“The emergence of Schmallenberg virus in ruminants in northern Europe demonstrates the current value and ongoing need for a robust surveillance system to work both nationally and internationally.
“The BVA welcomes the establishment of the advisory group and particularly the wide range of veterinary expertise and experience that is represented on the group. It is important that views from both veterinary practitioners and veterinary scientists are fed into this review.
“While we understand that AHVLA and Defra must ensure value for money from the surveillance network, any future model must be shaped by good surveillance strategies, not the need to cut costs.
“We urge all practitioners in England and Wales to contribute to the discussions by completing the online survey.
“We look forward to engaging with the advisory group as it carries out the review and beyond.”
The University of Surrey has announced that it is to launch a new school of veterinary medicine in 2014.
According to the University, the new school will embrace the 'One Health - One Medicine' philosophy and will include the development of a unique research-led veterinary medicine degree programme with an emphasis on research, veterinary pathology and livestock medicine.
The new school will be based at the University of Surrey's Manor Park site in Guildford, in order to encourage collaboration of students and staff from different disciplines, with those studying towards a veterinary medicine qualification being exposed to engineering and physics as well as receiving training in core business skills.
The new School of Veterinary Medicine at Surrey will be delivered through collaborations with key partners including: the Animal Health and Veterinary Laboratories Agency (AHVLA), the BBSRC Pirbright Institute, the Veterinary Medicines Directorate (VMD), Fitzpatrick Referrals, Liphook Equine Hospital and Westpoint Farm Vets. The University says it is looking to extend its relationships with regional veterinary practices over the coming year.
Students will also be exposed to global issues concerning animal health through the University Global Partnership Network (UGPN), a trilateral agreement between Surrey, North Carolina State and São Paulo Universities through teaching collaborations, summer scholarships and research exchanges.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: "As a research-intensive University we have the expertise, reputation, technical and business skills which our students can benefit from, allowing us to train the veterinary leaders of the future. Combining state-of-the-art facilities, our unique partnerships and a campus location, the new School will provide a stimulating environment not only for undergraduates, but for the professional development training of qualified veterinary surgeons."
Professor John Fazakerley, Director of The Pirbright Institute, said: "This is good news for the UK veterinary research community. The Pirbright Institute currently works in close collaboration with the University of Surrey on research that benefits animal health and welfare; we very much look forward to building on this established and growing association as the new school of veterinary medicine is launched. There is an important place for trained veterinarians in scientific research and we are delighted that the University has decided to emphasise these areas in particular."
Professor Andy Durham of the Liphook Equine Hospital said: "The new School of Veterinary Medicine development programme at the University of Surrey is ideally timed to provide an alternative to the traditional veterinary education and to respond to the demands of a changing profession with fresh plans, ideas and enthusiasm. Enticing newly developed facilities make Guildford an excellent student town and with several collaborative specialist partners within the locality the new School of Veterinary Medicine is perfectly placed geographically to provide a veterinary education fitting for the 21st century."
The University is also in consultation with the Royal College of Veterinary Surgeons. Freda Andrews, Head of Education at the RCVS, said: "We were pleased to meet Professor Sir Christopher Snowden, President and Vice-Chancellor and his colleagues from the University of Surrey recently, and interested to hear their proposals to develop a new School of Veterinary Medicine. We will be working with them over the coming months to develop a timetable for considering the new programme against our accreditation standards. The monitoring process will take a number of years."
The University says it has already laid the foundations for the new School through its expansion of teaching and research activities in its Faculty of Health and Medical Sciences, including the launch of the BSc programme in Veterinary Biosciences in 2009 and in October of this year a new MSc in Veterinary Microbiology. A new MSc in Veterinary Pathology is also currently under development.
The University says that over the next 12 months it will be recruiting new academic staff, attracting the first cohort of students and beginning building works in preparation for the first cohort of students in 2014.
The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.
Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.
Responses must be submitted before 23:59 on 26th September 2025
https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey
Norbrook Laboratories has launched Cefimam DC intramammary ointment, a new dry cow preparation containing the 4th generation cephalosporin, cefquinome.
The company has also released a Polish language version of its Best Practice Guide for On-Farm Mastitis Control, in response to demand from producers with non-English speaking farm-hands.
Norbrook vet Chris Geddes said: "I believe this is the first time that such a guide has been produced to cater for farm-hands of a different nationality working within the UK. Good mastitis management starts with good education; giving everyone on the farm the same opportunity for learning the best techniques for prevention means that we help minimise incidences of mastitis, which costs the dairy industry millions of pounds in lost revenue every year.
"This prevention includes a thorough and consistent approach to dry cow management. The early drying off period is often a risky time, when pre-existing subclinical infections can bed-in. The cow is also at increased risk of gaining new infections due to lack of udder hygiene procedures that would normally occur at milking, and weakened immunity as she approaches calving. Our new cefquinome preparation is a valuable addition to have in the treatment armoury for dry cow management. It has broad-spectrum activity and high cellular penetration to help tackle hard-to-manage cases with the aim of returning to maximum productivity by the start of the milking season."
Cefimam DC will be available at all veterinary wholesalers in packs of 24x and 120x 8g intramammary tubes. Vets can obtain both English and Polish versions of the Best Practice Guide for On-Farm Mastitis Control from Territory Managers.
For further information or copies of the Best Practice Guide for On-Farm Mastitis Control in English or Polish, contact your Territory Manager or call Norbrook GB head office on 01536 741 147.
The move comes as the whole agriculture industry, co-ordinated by agricultural and food industry alliance RUMA (which promotes responsible use of medicines in farming), looks to build on the recent 10% reduction in use of antibiotics to treat farm animals.
The BCVA’s Dr Elizabeth Berry, who prepared the recommendations, said that whilst the responsible use of antibiotics has been promoted for many years across farming sectors, there is still the potential to reduce use in some areas and to move away from products which are important for human health.
She said: "This is an official position from BCVA to our members but we would like to see all in the cattle sectors embrace these recommendations in the understanding that we need to play our part in increasing responsible use of antibiotics.
"Work still needs to be done to establish the levels currently being used in cattle so that appropriate targets can be set but there are measures that can immediately be adopted.
"So we are recommending reducing both the overall amount of antibiotics used in cattle practice and minimising the use of the high priority CIAs – namely third and fourth generation cephalosporins, fluoroquinolones and colistin. These drugs should only be used where they have been demonstrated by sensitivity testing to be the only suitable choice to avoid unnecessary suffering."
The BCVA, which has over 1,100 practising members covering around 85% of vets working with cattle, is also recommending that use of antibiotics as a preventative treatment is avoided wherever possible as long as animal welfare is not compromised.
Dr Berry added: "Where preventative treatment – or prophylaxis – is used it should be regarded as an interim measure whilst alternative management or vaccination strategies are implemented.
"For example, all cows which comply with recommendations for using an internal teat sealant should be considered for non-antibiotic treatments at drying off."
The BCVA continues to advise that every farm should have a herd health plan which embraces all of the disease control strategies appropriate for disease reduction on that farm. In addition, farm management best practice should be followed, such as the guidelines issued by Red Tractor farm assurance.
Dr Berry says BCVA further recommends that all herds should establish their BVD status and eradicate the disease where it is found. "BVD can have a detrimental effect on incidence of many diseases and its eradication will have a significant impact on the need for antimicrobial use.
"We also continue to recommend the use of diagnostics to identify disease so that appropriate treatments can be selected and vaccination programmes instituted to prevent or reduce the severity of disease."
BCVA’s confirmation of its official position has been welcomed by RUMA. Secretary General John FitzGerald says that while RUMA’s promotion of responsible use over the past 20 years means the UK remains among the lower users of antibiotics in farming in Europe1, more needs to be done.
"The BCVA’s position is clear and leaves no doubt that action needs to be taken,” says Mr FitzGerald. “It is underpinned by science, recognising that banning preventative use outright or access to critically important antibiotics is not an answer. Both are important tools in fighting disease and preventing suffering so we still need them – but we need to use them more strategically and only when no other options exist."
The complete list of guidelines can be downloaded from the BCVA website www.bcva.eu.
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.